This review comprehensively evaluates the integration of sensing and therapy using nanoplatforms loaded with antibiotics, antimicrobial peptides, anti‐inflammatory agents, and gene‐regulatory molecules and highlights how these platforms optimize therapeutic windows by enhancing local drug bioavailability while minimizing systemic off‐target toxicity.
Abstract
Sepsis remains a life‐threatening syndrome characterized by dynamic immune dysregulation and multi‐organ failure. Stimulus‐responsive nanoplatforms, which function as “biomarker‐triggered” therapeutic systems, have emerged as a frontier in precision sepsis management. These platforms are engineered to autonomously sense pathological hallmarks within the sepsis microenvironment—such as fluctuations in pH, reactive oxygen species (ROS), and specific enzymatic over‐expression—thereby enabling precise, spatiotemporal drug release. Unlike conventional static therapies, these “smart” nanoplatforms modulate therapeutic intervention in real‐time based on disease progression. This review comprehensively evaluates the integration of sensing and therapy using nanoplatforms loaded with antibiotics, antimicrobial peptides, anti‐inflammatory agents, and gene‐regulatory molecules. We highlight how these platforms optimize therapeutic windows by enhancing local drug bioavailability while minimizing systemic off‐target toxicity. Furthermore, we discuss the current hurdles in clinical translation, including patient‐specific biomarker variability and the complexity of scalable fabrication. Finally, we propose future directions, emphasizing the synergy of real‐time biosensing, artificial intelligence (AI), and multimodal “theranostic” platforms to achieve stage‐specific, personalized interventions. These advancements hold the potential to redefine sepsis management by shifting from “one‐size‐fits‐all” treatments to biomarker‐driven precision medicine.
Abstract Sepsis is a complex and life-threatening syndrome driven by a dysregulated host response to infection, involving persistent oxidative stress, excessive inflammation, immune paralysis, metabolic disturbance, and progressive organ dysfunction. Although substantial advances have been achieved in supportive therap...
Ye-Sen Shou, Yu-Kun Liu, Xuan Zhao et al.· International Journal of Nan...· 0 citations
ABSTRACT Biomimetic therapies hold great promise for treating intractable diseases, yet their translation is often hindered by dysfunction—the loss of intended biological function upon exposure to pathological microenvironments. This challenge is well exemplified by reconstituted high‐density lipoprotein (rHDL), a clin...
Han Zhou, Lei Zhang, Xing-Yu Cai et al.· Advancement of science· 0 citations
Persistent Post-COVID Syndrome (PPCS), commonly known as Long COVID, has emerged as a major global health
challenge affecting millions of individuals after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Its
heterogeneous clinical manifestations, prolonged symptom duration, and complex pathophys...
S. S, Genesis Mgp, Gopukumar· Nanomedicine & Nanotechn...· 0 citations
Smart nanoformulations have emerged as promising platforms in precision medicine by enabling controlled drug delivery, improved therapeutic targeting, enhanced bioavailability, and potential reductions in systemic toxicity. Conventional drug delivery systems often encounter limitations associated with poor aqueous solu...
A. Sonia, A. Ansar, D. Jayachandran et al.· International Journal of Dru...· 0 citations
The ubiquity of Micro- and nanoplastics (MP/NPs) pollution has reached a critical point, with these synthetic particles now detected across all environmental compartments and within human systemic circulation. As the global landscape faces an escalating frequency of viral outbreaks, there is an urgent need to understan...
D. M. Gómez-Gallego, Juan C. Hernandez· Frontiers in Virology· 0 citations
Sepsis is a life‐threatening systemic inflammatory syndrome frequently accompanied by multi‐organ dysfunction, with the liver being one of the most vulnerable target organs. However, the lack of effective real‐time imaging strategies hinders early diagnosis of sepsis‐associated hepatic injury. Herein, we report a biomi...